The global genotyping assay market size was USD 17.7 Billion in 2020 and is expected to register a robust CAGR of 22.4% during the forecast period. Key factors driving market revenue growth are increasing prevalence of genetic disorders such as Turner syndrome, Alzheimer’s, hemophilia, and Parkinson’s, and rising demand for genotyping assays globally.
Genotyping assay technology is commonly used in determining DNA sequences or identifying variations in individual’s genetic composition and comparing it with other individuals’ sequences or reference sequences. Advancements in genomics and genotyping enable researchers to explore various genetic deviations such as SNPs and structural changes in DNA. PCR, sequencing, capillary electrophoresis, and MALDI-TOF are some of the widely used genotyping techniques. Rising funding from governments to support genotyping assays and increasing awareness among individuals about importance of these assays are boosting revenue growth of the global market. Rising investments by key players in R&D for developing new and more enhanced products is expected to boost market revenue growth over the forecast period.
Moreover, benefits of utilizing genotyping assay technology in various sectors such as food safety and quality, veterinary needs at inaccessible and industrial units, and increasing demand for animal and plant genome analysis are expected to open new revenue opportunities for major players operating in the global market during the forecast period.
Request a Sample@ https://qyresearchmedical.com/sample/118913
Driver: Deteriorating DNA Sequencing Costs and Advancements in Genotyping Techniques
Increasing prevalence of genetic and chronic disorders is resulting in high need for using genotyping techniques for accurate and rapid analysis. Constant focus and investments by major players in technological developments is leading to launch of novel products with reduced process time and automation. Advanced equipment is easy to operate and aids in analyzing multiple parameter testing. Advanced PCR techniques, sequencing, or capillary electrophoresis aid in providing quick analysis, precise sequencing, and high efficiency. This has reduced overall cost required for DNA sequencing, total genomic, and genotyping project costs.
Restraints: High Equipment Costs and Stringent Regulatory Policies
High capital investments required for deployment of genotyping assay instruments is a major factor that can negatively affect revenue growth of the global genotyping assay market during the forecast period. Additionally, high maintenance and labor costs, and need to manage vast volume of data could hamper market revenue growth. Moreover, strict guidelines on gene sequencing and regulations on manufacturing of certain products can limit market revenue growth between 2021 and 2030.
Product and Service Outlook:
On the basis of product and services, the global genotyping assay market is segmented into reagents and kits, genotyping services, instruments, and bioinformatics. The reagents and kits segment is expected to dominate in terms of revenue share in the global market during the forecast period. This growth is attributed to factors such as high demand for reagents, coupled with rising number of genotyping testing globally, availability of enough funding to support research activities, and launch of new and more advanced reagents.
Based on technology, the global genotyping assay market is segmented into PCR, microarrays, sequencing, NGS, capillary electrophoresis, MALDI-TOF, and others. Among these, the sequencing segment is expected to account for largest revenue share over the forecast period, owing to ongoing technological advancements in the field of genotyping assays, accessibility to high-speed sequencing, and increasing application of DNA sequencing across the globe. PCR segment is expected to register a robust revenue CAGR during the forecast period, owing to factors such as rising demand for PCR in various applications such as forensics, prenatal, and genetic testing, and higher adoption of novel PCR techniques in various countries across the world.
Based on application, the global market is segmented into pharmacogenomics, diagnostic and personalized medicine, agricultural biotechnology, animal genetics, and others. Pharmacogenomics segment accounted for the largest revenue share in 2020 and is expected to register substantially high revenue growth rate during the forecast period. This growth is attributable to rising demand for genotyping in diagnostics and need to predict drug efficacy. Increasing demand for personalized medicines is expected to boost revenue growth of the diagnostic and personalized medicine segment over the forecast period.
Based on end-use, the global genotyping assay market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others, including animal and aqua genetics companies, greenhouses, and farms. Among these, pharmaceutical and biopharmaceutical companies segment is expected to account for largest revenue share during the forecast period. Increasing need for genotyping assay and pharmacogenomics for drug discovery and rising demand for personalized medicines because of rapidly increasing cases of genetic diseases are factors supporting revenue growth of this segment.
Based on regional analysis, North America accounted for largest revenue share in 2020, and is expected to continue to with its dominance over the forecast period. This can be attributed to factors including presence of advanced healthcare infrastructure and facilities with latest technologies and instruments. The markets in United States and Canada are major revenue contributors in the North America market. Moreover, increasing funding by governments of these countries for R&D activities in the field of genotyping and presence of a large number of companies are some key factors boosting revenue growth of the genotyping assay market in this region.
Europe is expected to account for significantly large revenue share between 2021 and 2030. Countries such as Germany, the United Kingdom, and France are major revenue contributors in this region. Increasing prevalence of genetic disorders, inclining healthcare expenditure, and growing private and public investments in genotyping and sequencing research & development are some key factors fueling revenue growth of the market in this region. Additionally, increasing use of genotyping assay in various applications such as drug discovery, agricultural, and plant and animal biotechnology is expected to boost revenue growth of the market in this region in the years to come.
The global genotyping assay market is highly competitive and consists of various emerging and well-established key players. Various strategies such as mergers, acquisitions, or collaborations are being incorporated by these market players to maintain strong footing in the market. Some major companies included in the market report are Thermo Fisher Scientific, Illumina, QIAGEN (Netherlands), Agilent Technologies, Danaher Corporation, Roche Diagnostics (Switzerland), GE Healthcare, Fluidigm Corporation, PerkinElmer, Eurofins Scientific (Luxembourg), Bio-Rad Laboratories, Pacific Biosciences of California, GENEWIZ, and Integrated DNA Technologies (US).
- In February 2021, Novacyt S.A launched PCR genotyping assay portfolio under the brand name SNPsig, to diagnose new variants of SARS-CoV-2.
- In February 2021, SOFIVA Genomics announced the launch of Taiwan’s first-ever genotyping test for endometrial cancer and is aiming to expand its precise medicine product line.
This report offers historical data points and forecasts and revenue growth at a global, regional, and country-level, and provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2019 to 2030.
For this study, Reports and Data has segmented the global genotyping assay market based on product and service, technology, application, end-use, and region:
Genotyping Assay Market Report Scope
Segments covered By Product & Service Outlook, Technology Outlook , Application Outlook, IEnd Use Outlook,Regional Outlook
By Product & Service Outlook
Reagents & Kits
Sequencers & Amplifiers
By Technology Outlook
Amplified Fragment Length Polymorphism
Restricted Fragment Length Polymorphism
Single-stranded Conformation Polymorphism
Allele-specific Oligonucleotide (ASO) Probes
Fluorescence In Situ Hybridization (FISH))
By Application Outlook
Diagnostic & Personalized Medicine
Microbial Genomic Studies
Aquaculture Breeding Studies
By End Use Outlook
Pharmaceutical and Biopharmaceutical Companies
Diagnostic and Research Laboratories
Animal and Aqua Genetics Companies
Middle East & Africa
TABLE OF CONTENT
1.1 Scope Of The Study
1.2 Market Segmentation
1.2.1 Genotyping Assay Market – By Product And Service
1.2.2 Genotyping Assay Market – By Technology
1.2.3 Genotyping Assay Market – By Application
1.2.4 Genotyping Assay Market – By End-User
1.2.5 Genotyping Assay Market – By Region
126.96.36.199 By Country
- Key Takeaways
3. Research Methodology
4. Genotyping Assay Market Landscape
4.2. PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia-Pacific – PEST Analysis
4.2.4 Latin America – PEST Analysis
4.2.5 Middle East & Africa – PEST Analysis
4.3. Expert Opinions
- Genotyping Assay Market – Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
- Genotyping Assay Market – Global Market Analysis
6.1 Genotyping Assay – Global Market Overview
6.2 Genotyping Assay – Global Market And Forecast 2019 to 2030
6.3 Market Positioning/Market Share
- Genotyping Assay Market – Revenue And Forecasts 2019 to 2030 – Product And Service
Buy quantitative research Report at discounted price – USD 1500 https://qyresearchmedical.com/report/checkout/118913/1500
You can place an order or ask any questions, please feel free to contact firstname.lastname@example.org | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: